Related Experiment Video
Updated: Mar 2, 2026

09:33
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
29.4K
Structural MRI correlates of amyotrophic lateral sclerosis progression
Joe Senda1,2, Naoki Atsuta1, Hirohisa Watanabe1,3
1Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Journal of Neurology, Neurosurgery, and Psychiatry
|May 15, 2017
Summary
Brain degeneration in amyotrophic lateral sclerosis (ALS) extends beyond motor pathways. Greater extra-motor involvement, particularly in the frontotemporal lobes and basal ganglia, indicates faster disease progression.
Area of Science:
- Neuroimaging
- Neurology
- Neurodegeneration
Background:
- Amyotrophic lateral sclerosis (ALS) exhibits variable brain degeneration and clinical progression.
- Structural MRI can detect brain changes reflecting ALS disease progression.
Purpose of the Study:
- To investigate the relationship between the spatial extent of brain degeneration and disease progression in ALS patients.
- To determine if extra-motor cortex and basal ganglia involvement predicts ALS progression.
Main Methods:
- 3-Tesla volumetric MRI and diffusion tensor imaging were used in 67 sporadic ALS patients and 38 controls.
- Patients were categorized into slow, intermediate, and rapid progression groups based on 6-month ALSFRS-R changes.
- Voxel-based morphometry and tract-based spatial statistics analyzed brain changes.
Main Results:
- ALS patients showed grey matter atrophy and decreased fractional anisotropy beyond the corticospinal tract (CST), notably in frontotemporal lobes and basal ganglia.
- The extent of brain changes correlated with the rate of functional decline (ΔALSFRS-R).
- Greater extra-motor and basal ganglia involvement was linked to faster disease progression.
Conclusions:
- The spatial extent of brain involvement, particularly in extra-motor regions, serves as an indicator of ALS progression.
- Widespread brain degeneration suggests a poorer prognosis and faster functional decline in ALS.

